{"url":"https://www.moneycontrol.com/news/business/lupin-launches-generic-version-of-oracea-capsules-in-us-12612481.html","title":"Lupin launches generic version of Oracea capsules in US","description":"The company said it has launched the medication, indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea, following approval from the US Food and Drug Administration (USFDA).Lupin, Glenmark recall drugs in US market: USFDA","content":"Drug maker Lupin on Wednesday said it has launched the generic version of Oracea capsules in the US market. The company said it has launched the medication, indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea, following approval from the US Food and Drug Administration (USFDA). As per the IQVIA MAT data, Doxycycline capsules (Oracea) had estimated annual sales of USD 128 million in the US. Shares of the company were trading 0.77 per cent up at Rs 1,617.35 apiece on the BSE. ","cleaned_content":"drug maker lupin on wednesday said it has launched the generic version of oracea capsules in the us market the company said it has launched the medication indicated for the treatment of inflammatory lesions papules and pustules of rosacea following approval from the us food and drug administration usfda as per the iqvia mat data doxycycline capsules oracea had estimated annual sales of usd \u003cONE_HUNDRED\u003e million in the us shares of the company were trading \u003cZERO_PERCENT\u003e up at rs \u003cONE_THOUSAND\u003e apiece on the bse","timestamp":"2024-04-10T18:21:00+05:30","market_timestamp":"2024-04-11T09:15:00+05:30","off_market_hours":true}